Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nailner Brush 2-in-1 is a **topical solution** for the treatment and prevention of **fungal nail infection (onychomycosis)**. The product uses a brush or pen applicator to deliver a liquid containing an acidic formula (notably ethyl lactate, lactic acid, citric acid) that fully penetrates the nail’s keratin layer, lowers the local pH, and creates an unfavorable environment for fungal pathogens. Additionally, it contains moisturizing and brightening agents (such as glycerin, resacetophenone, and ascorbyl lactoside) to improve nail appearance, helping to reduce discoloration and support healthy nail regrowth. The therapeutic effect is not the result of a specific antifungal pharmaceutical agent but rather from the alteration of the nail microenvironment to inhibit fungal proliferation[1][2][3][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nailner Brush 2-in-1.